Pharming the human lymph node
- 1 October 1994
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 3 (10), 1057-1060
- https://doi.org/10.1517/13543784.3.10.1057
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Tumor-associated antigens recognized by human monoclonal antibodiesAnnals of Surgical Oncology, 1994
- Management of the regional lymph nodes in patients with cutaneous malignant melanomaWorld Journal of Surgery, 1992
- Potential of human lymph node cells for antitumor activity mediated by interferon gammaCancer, 1991
- Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against EndotoxinNew England Journal of Medicine, 1991
- Man-made antibodiesNature, 1991
- Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.Proceedings of the National Academy of Sciences, 1986
- UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas.Proceedings of the National Academy of Sciences, 1983
- The use of lymphocytes from axillary lymph nodes of mastectomy patients to generate human monoclonal antibodiesEuropean Journal of Cancer and Clinical Oncology, 1981
- Generation of human monoclonal antibodies reactive with human mammary carcinoma cells.Proceedings of the National Academy of Sciences, 1980
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975